跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIO-IRBESARTAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIO-IRBESARTAN
Authorized
STANDARD
BIO-IRBESARTAN
biomed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c8735df21b662f05
Company
biomed pharma
Type
Standard
Approval Details
Approval Id
c8735df21b662f05
Drug Approval Canada Name
BIO-IRBESARTAN
Product Name
BIO-IRBESARTAN
Status
Cancelled Post Market
Status Date
2022-07-19
Original Market Date
2016-08-17
Din
02446162
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.08
Atc Original
C09CA04 IRBESARTAN
Atc Name
c 09 ca 04
Aig Number
0131700003
Company Name
biomed pharma
Company Address
1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8
Active Ingredients
IRBESARTAN
300 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c8735df21b662f05
Type
Standard
Back to Health Canada Approvals